Mild cognitive impairment. Survey of attitudes of specialists and general physicians;Deterioro cognitivo leve encuesta sobre actitudes de medicos especialistas y generalistas

Medicina

Volumn 67, Issue 1, 2007, Pages 19-25

  Serrano, Cecilia M ^a,b   Allegri, Ricardo F ^a,b   Caramelli, Paulo ^c   Taragano, Fernando E ^b   Camera, Luis ^d  

^a Hospital General de Agudos Dr Abel Zubizarreta   (Argentina)

^b CEMIC   (Argentina)

^c Unidad de Neurologia Cognitiva y del Comportamiento   (Brazil)

^d HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Alzheimer's disease; Data collection; Dementia; Mild cognitive impairment

Indexed keywords

ALPHA TOCOPHEROL; CHOLINESTERASE INHIBITOR; MEMANTINE;

ADULT; AGED; ALZHEIMER DISEASE; ARGENTINA; ARTICLE; BRAZIL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MALE; MEDICAL EXPERT; MEDICAL SPECIALIST; NEUROLOGY; PHYSICIAN ATTITUDE; PSYCHIATRIST; QUESTIONNAIRE; STANDARDIZATION; TREATMENT PLANNING;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ATTITUDE OF HEALTH PERSONNEL; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S ROLE; PROFESSIONAL PRACTICE; SEVERITY OF ILLNESS INDEX;

EID: 33947728233     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Plum F. Dementia: an approaching epidemic. Nature 1979; 279: 372-3.
2. Wells CE. A deluge of dementia. Psychosomatics 1981; 22: 837-8.
3. Allegri RF, Laurent B, Thomas Anterion C, Serrano CM. La memoria en el envejecimiento, el deterioro cognitivo leve y las demencias. En Mangone CA, Allegri RF, Arizaga RL, Ollari JA (eds): Demencia: enfoque multidisciplinario. 3a Ed. Buenos Aires: Editorial Polemos, 2005, p 351-72.
4. Laurent B, Anterion C, y Allegri RF. Memorie et demence. Rev Neurol (Paris) 1998; 154 (Suppl 2): S33-49.
5. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987; 76: 465-79.
6. Jorm AF. The epidemiology of Alzheimer's disease and Related Disorders. London: Chapman and Hall, 1990.
7. Mangone CA, Allegri RF, Arizaga RL, Ollari JA. Epidemiología de la Demencia en países latinoamericanos. Rev Neuropsicol Neuropsiquatr y Neuroc 1999; 1: 1-4.
8. Arizaga RL. Epidemiología de las demencias. En Mangone CA, Allegri RF, Arizaga RL y Ollari JA. (eds). Enfermedad de Alzheimer: enfoque actual. Buenos Aires: Editorial Argentum, 1995: p 62-128.
9. Arizaga RL. Epidemiología. En: Mangone CA, Allegri RF, Arizaga RL y Ollari JA (Eds). Demencia: enfoque multidisciplinario. Buenos Aires: Polemos 2005, p 37-60.
10. Kral VC. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962; 86: 257-60.
11. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical changes - report of National Institute of Mental Health Work Group. Dev Neuropsychol 1986; 2: 261-76.
12. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: Predictors of Dementia. Neurology 1991; 41: 1006-9.
13. Petersen RC, Smith G, Waring S, Ivnick R, Kokmen E, Tangalos E. Aging, Memory and Mild Cognitive Impairment. Int Psychogeriatr. 1997; 9: 37-43.
14. Petersen RC, Smith GE, Waring SC, Ivnick RJ, Tangalos E, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-8.
15. Petersen RC. Diagnosis of Dementia: diagnostic criteria, rating and early detection. In Dementia Update. Educational Program Syllabus. American Academy of Neurology, 2000, p 3fd. 34/36.
16. Petersen RC. Normal aging, mild cognitive impairment, and early Alzheimer's disease. Neurologist 1995; 1: 326-44.
17. Laurent B, Allegri RF, Thomas Anterion C. La memoria y el envejecimiento. En Mangone CA, Allegri RF, Arizaga RL, Ollari JA (Eds): Demencia: enfoque multidisciplinario. Buenos Aires: Sagitario 1997, p 351-72.
18. Larrieu A, Letenneur L, Orgogozo J, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002; 59: 1594-9.
19. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001; 56: 37-42.
20. Ebly E, Hogan D, Parhad I. Cognitive impairment in the nondemented elderly. Arch Neurol 1995; 52: 612-9.
21. Barker A, Jones R, Jennison C. A prevalence study of age-associated memory impairment. Br J Psychiatry 1995; 167: 642-8.
22. Coria F, Gomez de Caso JA, Minguez F, Rodriquez-Artalejo F, Claveria LE. Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatry 1993; 56: 973-6.
23. Palmer K, Wang H, Backman L, Winblad B, Fratiglioni L. Differential evolution of cognitive impairment in non-demented older persons: results from the Kungsholmen project. Am J Psychiatry 2002; 159: 436-42.
24. De Carli C. Mild cognitive impairment: prevalence, prognosis, etiology and treatment. Lancet Neurol, 2003; 2: 15-21.
25. Dubois B and Verstidal P. Issues in Diagnosis, therapeutic strategies and Management of MCI disease. MCI Forum, 2003; 2: p 1-10.
26. Pagés Larraya F, Grasso L, Marí G. Prevalencia de las demencias de tipo Alzheimer, demencias vasculares y otras demencias en la República Argentina. Rev Neurol Arg 2004; 29: 148-53.
27. Serrano CM y Allegri RF. Tratamiento Farmacológico de las Demencias. En Wikinski S y Jufre G (eds). El abordaje Farmacológico en el Paciente Psiquiátrico Adulto. Buenos Aires: Panamericana, 2005.
28. Gifford DR y Cummings JL. Evaluating dementia screening tests. Neurology 1999; 52: 224-7.
29. Allegri RF, Lorenzo J, Mangone CA. Evaluación neuropsicológica en las demencias. En: Mangone CA, Allegri RF, Arizaga RL, Ollari JA (eds). Demencias: Enfoque multidisciplinario de Buenos Aires, Polemos, 2005.
30. Allegri RF, Harris P, Drake M: Evaluación Neuropsicológica. En:: Quiroga P y Rohde G (eds). Psicogeriatría: bases conceptuales. Ediciones de la Sociedad de Neurología, Psiquiatría y Neurocirugía, Chile, 2002.
31. Cummings JL, Mega MS. Neuropsychiatry and Behavioral Neuroscience. Oxford: University Press, 2003.
32. Somerfield M, Weisman C, Ury C, Chase W, Folstein M. Physician practices in the diagnosis of dementing disorders. J Am Geriatric Soc 1991; 39: 172-5.
33. Zec RF. Neuropsychological functioning in Alzheimer's disease. In Parks RW, Zec RF, Wilson RS (eds). Neuropsychology of Alzheimer's disease and other dementias. New York: Oxford University Press, 1993: p 3-80.
34. Petersen RC. Conceptual Overview. In Petersen RC (ed.). Mild Cognitive Impairment: aging to Alzheimer's disease. New York: Oxford University Press 2003, p 1-14.
35. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impairment individuals. JAMA 1995; 273: 1274-78.
36. Harris P, Drake M, Allegri RF. Deterioro cognitivo leve: en búsqueda de la predemencia. Acta Psiquiatr Psicol Am Lat 2001; 47: 11-20.
37. Allegri RF, Drake M, Harris P, Serrano CM, Taragano FE. Intrusions in verbal learning in mild cognitive impairment: prodromal Alzheimer's disease. Neurology 2005; Suppl 1: A165.
38. Drake M, Butman J, Fontan L, et al. Screening for mild cognitive impairment: usefulness of the 7-Minute Screen test. Actas Esp Psiquiatr 2003; 31: 252-5.
39. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000; 55: 1847-53.
40. Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol 2004; 3: 246-8.
41. Kaye JA, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly person destined to develop dementia. Neurology 1997; 48: 1297-04.
42. Jack CR, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49: 786-94.
43. Bobinski M, de Leon MJ, Convit A, et al. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 1999; 353: 38-40.
44. Xu Y, Jack CR, Petersen RC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000; 54: 1760-7.
45. Johnson KA, Albert MS. Functional Imaging. In: Petersen RC (ed.). Mild cognitive impairment: aging to Alzheimer's disease. New York: Oxford University Press, 2003, p 133-48.
46. Petersen RC. Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2003b; 2: 646-53.
47. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment N Engl J Med 2005; 352: 2378-88.
48. Visser PJ, Scheltens P, Verthey FRJ. Do MCI criteria in drug trials accurately identify subjects wth predementia Alzheimer's disease? J Neurol Neurosurg Psychiatty 2005; 76: 1348-54.